
Tango Therapeutics (TNGX) Earnings Dates & Reports
Tango Therapeutics (TNGX) Most Recent Earnings
Report DateMay 12, 2025
Period EndingQ1 2025
Est. EPS-$0.35
Actual EPS-$0.36
EarningsMiss
Tango Therapeutics (TNGX) Earnings
View the latest Tango Therapeutics (TNGX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Tango Therapeutics (TNGX)
Order type
Buy in
Order amount
Est. shares
0 shares
Tango Therapeutics (TNGX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Tango Therapeutics (TNGX) Latest Earnings
The value each TNGX share was expected to gain vs. the value each share gained.
Tango Therapeutics (TNGX) reported its most recent earnings on May 12, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.36. This exceeded analysts' expectations of -$0.35 by 2.86%, marking a Miss.
For comparison, Tango Therapeutics reported EPS of -$0.35 in the same quarter last year.
The company is expected to announce its next earnings report on 08/06/2025, with analysts projecting an EPS of $0.
Tango Therapeutics (TNGX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Aug 6, 2025 | – | Next earnings call Aug. 6, 2025 | ||
Q1 2025May 12, 2025 | -$0.35 | -$0.36 | +2.86% | |
Q4 2024Feb 27, 2025 | -$0.34 | -$0.35 | +2.94% | |
Q3 2024Nov 6, 2024 | -$0.37 | -$0.27 | -27.03% | |
Q2 2024Aug 7, 2024 | -$0.34 | -$0.24 | -29.41% | |
Tango Therapeutics (TNGX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Tango Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 12, 2025 | — | — | — |
Feb 27, 2025 | — | — | — |
Nov 6, 2024 | — | — | — |
Aug 7, 2024 | — | — | — |
Tango Therapeutics (TNGX) Earnings FAQs
Tango Therapeutics (TNGX) last reported earnings on May 12, 2025 for Q1 2025, posting an EPS of -$0.36, which Miss the estimate of -$0.35 by 2.86%.
For Q1 2025, Tango Therapeutics (TNGX) reported an EPS of -$0.36, missing analysts' estimate of -$0.35 by 2.86%.
For Q1 2025, Tango Therapeutics (TNGX) Miss expectations with an actual EPS of -$0.36 vs. an estimated EPS of -$0.35.
Following the last earnings report on May 12, 2025, Tango Therapeutics (TNGX)'s stock price moved — from — to —.
The next Tango Therapeutics (TNGX) earnings call is scheduled for Aug. 6, 2025, where executives will discuss financial results and outlook.